Cargando…

Editorial: Real World Outcomes of Lymphoma From India

Detalles Bibliográficos
Autores principales:	Kumar, Lalit, KN, Naresh, Gujral, Sumeet, Kulkarni, Padmaj, Stockler, Martin R., Nair, Reena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344973/ https://www.ncbi.nlm.nih.gov/pubmed/35928874 http://dx.doi.org/10.3389/fonc.2022.922370

Ejemplares similares

Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India
por: Bhurani, Dinesh, et al.
Publicado: (2022)

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
por: Nair, Reena, et al.
Publicado: (2023)

Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India
por: Tembhare, Prashant R., et al.
Publicado: (2022)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India
por: Gogia, Ajay, et al.
Publicado: (2021)

Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review
por: Radhakrishnan, Vivek S., et al.
Publicado: (2022)

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective
por: Ramakrishnan, Sharanya, et al.
Publicado: (2022)

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China
por: Gao, Fenghua, et al.
Publicado: (2022)

Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry
por: Nair, Reena, et al.
Publicado: (2022)

Editorial: Digital health and real-world evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2023)

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
por: Patkar, Nikhil, et al.
Publicado: (2019)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients
por: Britschgi, Christian, et al.
Publicado: (2020)

Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology
por: Agarwala, Vivek, et al.
Publicado: (2023)

Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
por: Cheeseman, Sue, et al.
Publicado: (2023)

Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020)

Editorial: The management of hematologic malignancies in lower-income countries
por: Ganesan, Prasanth, et al.
Publicado: (2023)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

Does Ethnicity Matter in Multiple Myeloma Risk Prediction in the Era of Genomics and Novel Agents? Evidence From Real-World Data
por: Farswan, Akanksha, et al.
Publicado: (2021)

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study
por: Wu, Meng, et al.
Publicado: (2022)

Editorial: Murine Models of Leukemia and Lymphoma
por: Cutucache, Christine E., et al.
Publicado: (2017)

Editorial: Cutaneous B-Cell Lymphomas
por: Alaibac, Mauro, et al.
Publicado: (2020)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
por: Liu, Weiping, et al.
Publicado: (2021)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
por: Cottini, Francesca, et al.
Publicado: (2021)

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
por: Zhu, Qiuhua, et al.
Publicado: (2021)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Editorial: Advances in the understanding and treatment of cutaneous lymphoma
por: Bernardelli, Andrea, et al.
Publicado: (2023)

Long-term treatment outcome of Castleman’s disease: A real-world experience
por: Min, Gi-June, et al.
Publicado: (2022)

Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients
por: Tembhare, Prashant R., et al.
Publicado: (2020)

CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences
por: Vitale, Candida, et al.
Publicado: (2020)

Outcomes of diffuse large B-cell lymphoma in elderly patients—real-world experience from a middle-income country setting
por: Sarker, Chandrayee, et al.
Publicado: (2021)

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
por: Li, Jia, et al.
Publicado: (2022)

Impact of Comorbidity Scores on the Overall Survival of Patients With Advanced Non-small Cell Lung Cancer: A Real-World Experience From Eastern India
por: M, Srikanth Goud, et al.
Publicado: (2022)

Editorial: Grappling with the Multifaceted World of the DNA Damage Response
por: Porro, Antonio
Publicado: (2016)

Clinical and Epidemiological Profile of Elderly Hodgkin’s Lymphoma in India
por: Sharma, Manish, et al.
Publicado: (2022)

Editorial: NK/T-Cell Lymphoma: Biology, Prognostics, Prediction, and Treatment
por: El Cheikh, Jean, et al.
Publicado: (2022)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India
por: Kadam Amare, Pratibha S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tjmvvucj9queoro0knbf1kkugb